Original language | English |
---|---|
Pages (from-to) | 12-12 |
Number of pages | 1 |
Journal | Annals of Oncology |
Volume | 21 |
DOIs | |
Publication status | Published - Oct 2010 |
Externally published | Yes |
Event | 35th European-Society-for-Medical-Oncology (ESMO) Congress - Milan, Italy Duration: 8 Oct 2010 → 12 Oct 2010 |
Phase 1/2 study of GSK2118436, a selective inhibitor of V600 mutant (MUT) braf kinase: evidence of activity in melanoma brain metastases (METS)
G. V. Long, R. F. Kefford, P. J. A. Carr, M. P. Brown, M. Curtis, B. Ma, P. Lebowitz, K. B. Kim, R. Kurzrock, G. Falchook
Research output: Contribution to journal › Meeting abstract › peer-review